[go: up one dir, main page]

FR3053333B1 - Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et un com-pose de niacinamide, et composition cosmetique le contenant - Google Patents

Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et un com-pose de niacinamide, et composition cosmetique le contenant Download PDF

Info

Publication number
FR3053333B1
FR3053333B1 FR1656175A FR1656175A FR3053333B1 FR 3053333 B1 FR3053333 B1 FR 3053333B1 FR 1656175 A FR1656175 A FR 1656175A FR 1656175 A FR1656175 A FR 1656175A FR 3053333 B1 FR3053333 B1 FR 3053333B1
Authority
FR
France
Prior art keywords
niacinamide
butan
hydroxyphenyl
ethoxy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1656175A
Other languages
English (en)
Other versions
FR3053333A1 (fr
Inventor
Sofiane Ouattara
Veronique Chevalier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1656175A priority Critical patent/FR3053333B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to ES17735414T priority patent/ES2784947T3/es
Priority to PCT/EP2017/065547 priority patent/WO2018001898A1/fr
Priority to RU2019102402A priority patent/RU2748269C2/ru
Priority to US16/311,906 priority patent/US10918582B2/en
Priority to EP17735414.9A priority patent/EP3478253B1/fr
Priority to BR112018076636-4A priority patent/BR112018076636B1/pt
Priority to JP2018568210A priority patent/JP6855512B2/ja
Priority to KR1020197002124A priority patent/KR102257407B1/ko
Priority to CN201780039213.7A priority patent/CN109414382B/zh
Publication of FR3053333A1 publication Critical patent/FR3053333A1/fr
Application granted granted Critical
Publication of FR3053333B1 publication Critical patent/FR3053333B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
FR1656175A 2016-06-30 2016-06-30 Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et un com-pose de niacinamide, et composition cosmetique le contenant Expired - Fee Related FR3053333B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR1656175A FR3053333B1 (fr) 2016-06-30 2016-06-30 Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et un com-pose de niacinamide, et composition cosmetique le contenant
KR1020197002124A KR102257407B1 (ko) 2016-06-30 2017-06-23 4-(3-에톡시-4-히드록시페닐)부탄-2-온 및 니아신아미드 화합물을 함유하는 액상 혼합물, 및 이를 함유하는 화장품 조성물
RU2019102402A RU2748269C2 (ru) 2016-06-30 2017-06-23 Жидкая смесь, содержащая 4-(3-этокси-4-гидроксифенил)бутан-2-он, никотинамидное соединение, и косметическая композиция, содержащая такую смесь
US16/311,906 US10918582B2 (en) 2016-06-30 2017-06-23 Liquid mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one, a niacinamide compound, and cosmetic composition containing same
EP17735414.9A EP3478253B1 (fr) 2016-06-30 2017-06-23 Mélange liquide contenant du 4-(3-éthoxy-4-hydroxyphényl)butan-2-one et un composé niacinamide, et composition cosmétique le contenant
BR112018076636-4A BR112018076636B1 (pt) 2016-06-30 2017-06-23 Mistura líquida, processo para preparação de uma mistura líquida, composição e processo de tratamento cosmético
ES17735414T ES2784947T3 (es) 2016-06-30 2017-06-23 Mezcla líquida que contiene 4-(3-etoxi-4-hidroxifenil)butan-2-ona, un compuesto de niacinamida y composición cosmética que la contiene
PCT/EP2017/065547 WO2018001898A1 (fr) 2016-06-30 2017-06-23 Mélange liquide contenant du 4-(3-éthoxy-4-hydroxyphényl)butan-2-one et un composé niacinamide, et composition cosmétique le contenant
CN201780039213.7A CN109414382B (zh) 2016-06-30 2017-06-23 含有4-(3-乙氧基-4-羟苯基)丁-2-酮和烟酰胺化合物的化妆品组合物
JP2018568210A JP6855512B2 (ja) 2016-06-30 2017-06-23 ４−（３−エトキシ−４−ヒドロキシフェニル）ブタン−２−オンとナイアシンアミド化合物とを含有する液体混合物、およびそれを含有する化粧料組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1656175A FR3053333B1 (fr) 2016-06-30 2016-06-30 Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et un com-pose de niacinamide, et composition cosmetique le contenant
FR1656175 2016-06-30

Publications (2)

Publication Number Publication Date
FR3053333A1 FR3053333A1 (fr) 2018-01-05
FR3053333B1 true FR3053333B1 (fr) 2018-07-27

Family

ID=56855695

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1656175A Expired - Fee Related FR3053333B1 (fr) 2016-06-30 2016-06-30 Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et un com-pose de niacinamide, et composition cosmetique le contenant

Country Status (10)

Country Link
US (1) US10918582B2 (fr)
EP (1) EP3478253B1 (fr)
JP (1) JP6855512B2 (fr)
KR (1) KR102257407B1 (fr)
CN (1) CN109414382B (fr)
BR (1) BR112018076636B1 (fr)
ES (1) ES2784947T3 (fr)
FR (1) FR3053333B1 (fr)
RU (1) RU2748269C2 (fr)
WO (1) WO2018001898A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3090273A1 (fr) 2018-12-21 2020-06-26 L'oreal Mélange antimicrobien contenant du 4-(3-éthoxy-4-hydroxyphényl)butan-2-one et du niacinamide, et composition le contenant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047182A1 (fr) * 1999-02-12 2000-08-17 The Procter & Gamble Company Compositions cosmetiques contenant des composes de vitamine b¿3?
US20030082219A1 (en) * 2001-10-01 2003-05-01 The Procter & Gamble Company Skin care compositions comprising low concentrations of skin treatment agents
DE10342856A1 (de) * 2003-09-15 2005-04-21 Basf Ag Pulverförmige Zubereitungen, enthaltend 2,4,6-Trianilino-p-(carbo-2'-ethylhexyl-1'-oxi)-1,3,5-triazin
US20100099766A1 (en) 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
GB0915964D0 (en) * 2009-09-11 2009-10-28 Reckitt Benckiser Healthcare I Cosmetic composition
FR2950884B1 (fr) 2009-10-01 2011-11-11 Oreal Utilisation de derives de vanilline comme conservateur, procede de conservation, composes et composition
FR2973227B1 (fr) * 2011-04-01 2014-08-08 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
FR2973228B1 (fr) * 2011-04-01 2014-08-01 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one

Also Published As

Publication number Publication date
JP6855512B2 (ja) 2021-04-07
EP3478253B1 (fr) 2020-02-12
JP2019522001A (ja) 2019-08-08
CN109414382B (zh) 2021-12-10
CN109414382A (zh) 2019-03-01
EP3478253A1 (fr) 2019-05-08
WO2018001898A1 (fr) 2018-01-04
ES2784947T3 (es) 2020-10-02
US10918582B2 (en) 2021-02-16
KR102257407B1 (ko) 2021-05-31
RU2748269C2 (ru) 2021-05-21
BR112018076636B1 (pt) 2022-04-12
RU2019102402A (ru) 2020-07-30
FR3053333A1 (fr) 2018-01-05
US20190201303A1 (en) 2019-07-04
BR112018076636A2 (pt) 2019-04-02
RU2019102402A3 (fr) 2020-07-30
KR20190021387A (ko) 2019-03-05

Similar Documents

Publication Publication Date Title
DK3490926T3 (da) Dispenseringsapparat til at tilføre ingredienser til kulsyreholdig drikkevarevæske og fremgangsmåde deraf
EP3426385A4 (fr) Compositions contenant des nanobulles dans un support liquide
MX2018013983A (es) Inhibidores g12c de kras.
EP3437495A4 (fr) Cartouche pour inhalateur d'arôme et inhalateur d'arôme
EP3483966A4 (fr) Matériau d'électrolyte, composition liquide le contenant et utilisation associée
IL283968A (en) Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof
EP3390626A4 (fr) Formulation liquide d'alpha-amylase
DK3526207T3 (da) Heterocykliske forbindelser med aktivitet som modulatorer af muscarine m1- og/eller m4-receptorer i behandling af cns-sygdomme og smerter
EP3302561A4 (fr) Combinaisons d'immunoconjugués anti-cd37 et d'anticorps anti-cd20
DK3412660T3 (da) Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme
IL271726A (en) Compositions and methods of use of 2-(4-chlorophenyl)-N-((2-(2, 6-doxopyridin-3-yl)-1-oxoisoinodolin-5-yl)methyl)2-2-difluoroacetamide
EP3556837A4 (fr) Composition détergente et composition d'aérosol de celle-ci
DK3556383T3 (da) Plasminogen til anvendelse ved behandling af diabetes
FR3040246B1 (fr) Laser terahertz, source terahertz et utilisation d'un tel laser terahertz
GB2578093B (en) Liquid pharmaceutical composition comprising RPL554 and HFA-134A
EP3718578C0 (fr) Composition pour hémostase et récipient comprenant celle-ci
EP3905900C0 (fr) Formulation de nicotine liquide
IL271464A (en) Nk-1 antagonist compositions and methods for use in treating depression
EP3555108A4 (fr) Matériau de stockage et de distribution d'hydrogène
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
EP3611206A4 (fr) Mélange de monomère, et composition durcissable contenant celui-ci
EP3470053A4 (fr) Composition cosmétique inodore et très stable
IT201700025666A1 (it) Composizione per l’uso nel trattamento dell’ipercolesterolemia e nella prevenzione di patologie cardiovascolari.
FR3053333B1 (fr) Melange liquide contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et un com-pose de niacinamide, et composition cosmetique le contenant
DK3503885T3 (da) Farmaceutisk præparat og fremgangsmåder til anvendelse heraf

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180105

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 5

ST Notification of lapse

Effective date: 20220205